Search research articles
Contact Us
Filters
Showing results (21-30 of 75) with videos related to
Page
of 8
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 9, 2024
Assessing Response to PSMA Radiopharmaceutical Therapies with Single SPECT Imaging at 24 Hours After Injection
Surekha Yadav, Fei Jiang, Sara Kurkowska, et al.
Practical Radiation Oncology
|
December 12, 2022
Validation of the Combination Gleason Score as an Independent Favorable Prognostic Factor in Prostate Cancer Treated With Dose-Escalated Radiation Therapy
Thomas J Quinn, Daniel Chapman, Jacob Parzen, et al.
Seminars in Radiation Oncology
|
June 18, 2023
Histology Specific Molecular Biomarkers: Ushering in a New Era of Precision Radiation Oncology
Philip Sutera, Heath Skinner, Matthew Witek, et al.
Prostate Cancer and Prostatic Diseases
|
August 11, 2024
Delayed definitive management of localized prostate cancer: what do we know?
Osama Mohamad, Yun Rose Li, Felix Feng, et al.
European Urology
|
May 18, 2024
Challenges and Opportunities in Establishing Appropriate Intermediate Endpoints Reflecting Patient Benefit: A Roadmap for Research and Clinical Application in Nonmetastatic Prostate Cancer
Sabine D Brookman-May, Marc Buyse, Stephen J Freedland, et al.
European Urology Oncology
|
April 19, 2020
Intermediate-risk Prostate Cancer: Stratification and Management
Felix Preisser, Matthew R Cooperberg, Juanita Crook, et al.
Clinical Epigenetics
|
May 5, 2022
Androgen receptor reprogramming demarcates prognostic, context-dependent gene sets in primary and metastatic prostate cancer
Tesa Severson, Xintao Qiu, Mohammed Alshalalfa, et al.
European Urology Focus
|
January 16, 2019
What Is Oligometastatic Prostate Cancer?
Michael Fraser, Bridget Koontz, Urban Emmenegger, et al.
Molecular Oncology
|
February 19, 2019
The long noncoding RNA HORAS5 mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional program
Abhijit Parolia, Erik Venalainen, Hui Xue, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 15, 2024
Prognostic factors in post-prostatectomy salvage radiotherapy setting with and without hormonotherapy: An individual patient data analysis of randomized trials from ICECaP database
Pascal Pommier, Wanling Xie, Praful Ravi, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 75) with videos related to
Sort By:
Page
of 8
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 9, 2024
Assessing Response to PSMA Radiopharmaceutical Therapies with Single SPECT Imaging at 24 Hours After Injection
Surekha Yadav, Fei Jiang, Sara Kurkowska, et al.
Practical Radiation Oncology
|
December 12, 2022
Validation of the Combination Gleason Score as an Independent Favorable Prognostic Factor in Prostate Cancer Treated With Dose-Escalated Radiation Therapy
Thomas J Quinn, Daniel Chapman, Jacob Parzen, et al.
Seminars in Radiation Oncology
|
June 18, 2023
Histology Specific Molecular Biomarkers: Ushering in a New Era of Precision Radiation Oncology
Philip Sutera, Heath Skinner, Matthew Witek, et al.
Prostate Cancer and Prostatic Diseases
|
August 11, 2024
Delayed definitive management of localized prostate cancer: what do we know?
Osama Mohamad, Yun Rose Li, Felix Feng, et al.
European Urology
|
May 18, 2024
Challenges and Opportunities in Establishing Appropriate Intermediate Endpoints Reflecting Patient Benefit: A Roadmap for Research and Clinical Application in Nonmetastatic Prostate Cancer
Sabine D Brookman-May, Marc Buyse, Stephen J Freedland, et al.
European Urology Oncology
|
April 19, 2020
Intermediate-risk Prostate Cancer: Stratification and Management
Felix Preisser, Matthew R Cooperberg, Juanita Crook, et al.
Clinical Epigenetics
|
May 5, 2022
Androgen receptor reprogramming demarcates prognostic, context-dependent gene sets in primary and metastatic prostate cancer
Tesa Severson, Xintao Qiu, Mohammed Alshalalfa, et al.
European Urology Focus
|
January 16, 2019
What Is Oligometastatic Prostate Cancer?
Michael Fraser, Bridget Koontz, Urban Emmenegger, et al.
Molecular Oncology
|
February 19, 2019
The long noncoding RNA HORAS5 mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional program
Abhijit Parolia, Erik Venalainen, Hui Xue, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 15, 2024
Prognostic factors in post-prostatectomy salvage radiotherapy setting with and without hormonotherapy: An individual patient data analysis of randomized trials from ICECaP database
Pascal Pommier, Wanling Xie, Praful Ravi, et al.
Page
of 8